Guangzhou Pharmaceutical Holdings Limited takes Chinese medicine modernization as one of its strategies in technological innovations, and concentrates on the development of new technologies, improvement and restructuring of the traditional Chinese medicinal products. It will endeavor, as steered by the market and motivated by scientific and technological innovations, to set up a new development model by taking Chinese medicine modernization as the breaking point. As at the end of the Tenth Five-Year Plan, the industrial output value of Guangzhou Pharmaceutical Holdings Limited is expected to amount to RMB10 billion, with its sales revenue and income tax paid reaching RMB13 billion and RMB1 billion, respectively. It will endeavor to become a large conglomerate with strong technology innovation capability, famous brands of products, a complete sales network and strong competitiveness.